Madam Speaker, I am glad the member brought up these two very profound issues that I could speak to at length.
I will start with pharmaceuticals. This is a real challenge for Canadians today. In the House, when we talk about the threat to universal health care and our conviction on this side to defend it, one of the key things the governing party keeps bringing up is that it is going to reduce costs by looking at some ways to come up with a pharmaceutical plan and that it is working on that.
CETA will cripple that initiative. We will not be allowed to do that. Anyone can read this in the document. The myths with regard to this are really frustrating. Every single day in every constituency, members have people who are suffering because of the cost of pharmaceuticals and health care.
Another thing I want to bring up, which we have not talked about at all, is innovation and research in pharmaceuticals. Government-sponsored research and innovation for particular types of cures for certain diseases is also going to be undermined by this deal. Intellectual property will be undermined by this deal.
When it comes to issues like dairy farmers being compensated, I do not understand how we can have the government, on one hand, championing the cause and making these kinds of promises, and then—